In vivo GluCEST MRI: Reproducibility, background contribution and source of glutamate changes in the MPTP model of Parkinson’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vivo GluCEST MRI: Reproducibility, background contribution and source of glutamate changes in the MPTP model of Parkinson’s disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-07
DOI
10.1038/s41598-018-21035-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice
- (2017) Rachelle Crescenzi et al. HIPPOCAMPUS
- Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum
- (2017) D R Roalf et al. MOLECULAR PSYCHIATRY
- Neural Circuit-Specialized Astrocytes: Transcriptomic, Proteomic, Morphological, and Functional Evidence
- (2017) Hua Chai et al. NEURON
- Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency
- (2016) Puneet Bagga et al. JOURNAL OF NEUROCHEMISTRY
- In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease
- (2016) Jérémy Pépin et al. NEUROIMAGE
- Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsy
- (2015) Kathryn Adamiak Davis et al. Science Translational Medicine
- In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy
- (2014) Rachelle Crescenzi et al. NEUROIMAGE
- In vivoNMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment
- (2013) Puneet Bagga et al. JOURNAL OF NEUROCHEMISTRY
- Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson’s Disease
- (2013) Fabrine S. M. Tristão et al. NEUROTOXICITY RESEARCH
- Neuroprotective Effect of Curcuminoids Against Inflammation-Mediated Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease
- (2012) Rudra P. Ojha et al. Journal of Neuroimmune Pharmacology
- Quantitative characterization of nuclear overhauser enhancement and amide proton transfer effects in the human brain at 7 tesla
- (2012) Dapeng Liu et al. MAGNETIC RESONANCE IN MEDICINE
- MR imaging of the amide-proton transfer effect and the pH-insensitive nuclear overhauser effect at 9.4 T
- (2012) Tao Jin et al. MAGNETIC RESONANCE IN MEDICINE
- Magnetic resonance imaging of glutamate
- (2012) Kejia Cai et al. NATURE MEDICINE
- Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens? A1H nuclear MRS study
- (2012) Carine Chassain et al. NMR IN BIOMEDICINE
- Imaging of glutamate neurotransmitter alterations in Alzheimer's disease
- (2012) Mohammad Haris et al. NMR IN BIOMEDICINE
- Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice
- (2011) Shih-jei Tsai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metabolic changes detected in vivo by 1H MRS in the MPTP-intoxicated mouse
- (2010) Carine Chassain et al. NMR IN BIOMEDICINE
- From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease
- (2009) Peter Jenner PARKINSONISM & RELATED DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started